Fiasp 100 Unit (Insulin Aspart SOLUTION) 100 UNIT

FIASP 100 Unit is a rapid-acting insulin solution designed for subcutaneous use. It is commonly used to manage blood glucose levels in diabetes care. This product is manufactured by Novo Nordisk Canada Inc.

Strength

100 UNIT

Pack Size

5X3ML

Manufacturer / TM Owner

NOVO NORDISK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

FIASP 100 Unit is primarily used for the management of diabetes, helping to control blood sugar levels. It is often administered before meals to address immediate insulin needs. This rapid-acting insulin is formulated to start working quickly, making it suitable for use in conjunction with long-acting insulin therapies. People often ask, 'What is FIASP used for?' and the answer is that it is designed to help manage glucose levels in diabetes care.

Side Effects

FIASP 100 Unit is designed to lower blood sugar levels quickly after administration. Users may experience effects such as reduced glucose levels shortly after injection. It is important to monitor blood sugar levels regularly to understand how this insulin solution works for individual needs.

Precautions & Warnings

FIASP 100 Unit should be handled with care, ensuring it is stored properly to maintain its effectiveness. It is important to follow the guidelines provided by healthcare professionals regarding administration and storage. Always check the solution for any particles or discoloration before use.

Avoid Interactions

FIASP 100 Unit may interact with other medications, including oral hypoglycemic agents and certain antihypertensive drugs. It is also important to be cautious when consuming alcohol, as it can affect blood sugar levels. Always consult with a healthcare provider to understand potential interactions.

Frequently Asked Questions

FIASP 100 Unit is used to manage blood glucose levels in people with diabetes. It is a rapid-acting insulin solution designed to be administered before meals.

FIASP 100 Unit should be stored in a refrigerator between 2°C and 8°C. It should not be frozen and should be protected from light.

Common side effects may include hypoglycemia, injection site reactions, and allergic reactions. Always monitor for any adverse effects and consult a healthcare provider if necessary.

FIASP 100 Unit can be used in combination with long-acting insulin therapies. It is important to follow the advice of a healthcare professional regarding the use of multiple insulin types.

FIASP 100 Unit is designed to start working rapidly after administration, typically within 10-20 minutes. It reaches its peak effect within 1-3 hours.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.